Muriel Lavie

1.9k total citations
23 papers, 769 citations indexed

About

Muriel Lavie is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Muriel Lavie has authored 23 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Epidemiology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Muriel Lavie's work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Muriel Lavie is often cited by papers focused on Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Muriel Lavie collaborates with scholars based in France, Belgium and Germany. Muriel Lavie's co-authors include Jean Dubuisson, Xavier Hanoulle, Anne Goffard, Czeslaw Wychowski, Christian Boucher, Nigel Grimsley, Cécile Voisset, Ngoc Vu‐Dac, Sofie Struyf and Jo Van Damme and has published in prestigious journals such as Hepatology, Journal of Virology and Frontiers in Immunology.

In The Last Decade

Muriel Lavie

23 papers receiving 757 citations

Peers

Muriel Lavie
Elke Bieck Germany
Yutaka Amako United States
Rohit Duggal United States
John Wickersham United States
Yun-Sook Lim South Korea
Elke Bieck Germany
Muriel Lavie
Citations per year, relative to Muriel Lavie Muriel Lavie (= 1×) peers Elke Bieck

Countries citing papers authored by Muriel Lavie

Since Specialization
Citations

This map shows the geographic impact of Muriel Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Lavie more than expected).

Fields of papers citing papers by Muriel Lavie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Lavie. The network helps show where Muriel Lavie may publish in the future.

Co-authorship network of co-authors of Muriel Lavie

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Lavie. A scholar is included among the top collaborators of Muriel Lavie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Lavie. Muriel Lavie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lavie, Muriel, Jean Dubuisson, & Sandrine Belouzard. (2022). SARS-CoV-2 Spike Furin Cleavage Site and S2′ Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner. Journal of Virology. 96(13). e0047422–e0047422. 27 indexed citations
2.
Desmarets, Lowiese, Nathalie Callens, Eik Hoffmann, et al.. (2022). A reporter cell line for the automated quantification of SARS-CoV-2 infection in living cells. Frontiers in Microbiology. 13. 1031204–1031204. 11 indexed citations
3.
Rivière, Céline, Véronique Pène, Muriel Lavie, et al.. (2019). Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus , Is a New Inhibitor of Hepatitis C Virus RNA Replication. Journal of Virology. 93(10). 30 indexed citations
4.
Lavie, Muriel, et al.. (2019). Role of the cytosolic domain of occludin in trafficking and hepatitis C virus infection. Traffic. 20(10). 753–773. 5 indexed citations
5.
Lavie, Muriel, et al.. (2019). Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine & Growth Factor Reviews. 50. 29–42. 28 indexed citations
6.
Dubuisson, Jean, et al.. (2019). Function of the HCV E1 Envelope Glycoprotein in Viral Entry and Assembly. Future Virology. 14(3). 171–184. 4 indexed citations
7.
Haddad, Juliano G., Xavier Hanoulle, Véronique Descamps, et al.. (2018). Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain. Journal of Virology. 92(20). 6 indexed citations
8.
Lavie, Muriel, Xavier Hanoulle, & Jean Dubuisson. (2018). Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies. Frontiers in Immunology. 9. 910–910. 85 indexed citations
9.
Lavie, Muriel & Jean Dubuisson. (2017). Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly. Biochimie. 141. 62–69. 40 indexed citations
11.
Lavie, Muriel, François Pénin, & Jean Dubuisson. (2015). HCV Envelope Glycoproteins in Evirion Assembly and Entry. Future Virology. 10(3). 297–312. 4 indexed citations
12.
Lavie, Muriel, et al.. (2013). Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis. Virology. 447(1-2). 221–232. 13 indexed citations
13.
Lavie, Muriel, Sofie Struyf, Rauf Bhat, et al.. (2012). Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment. Cancer Immunology Immunotherapy. 61(11). 2113–2123. 49 indexed citations
14.
Rocha‐Perugini, Vera, Muriel Lavie, David Delgrange, et al.. (2009). The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry. BMC Microbiology. 9(1). 111–111. 28 indexed citations
15.
Lavie, Muriel, Anne Goffard, & Jean Dubuisson. (2007). Assembly of a Functional HCV Glycoprotein Heterodimer. Current Issues in Molecular Biology. 9(2). 71–86. 67 indexed citations
16.
Voisset, Cécile, Muriel Lavie, François Helle, et al.. (2007). Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cellular Microbiology. 10(3). 606–617. 66 indexed citations
17.
Lavie, Muriel, et al.. (2006). Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system. Hepatology. 44(6). 1626–1634. 75 indexed citations
18.
Lavie, Muriel, Anne Goffard, & Jean Dubuisson. (2006). HCV Glycoproteins: Assembly of a Functional E1–E2 Heterodimer. Europe PMC (PubMed Central). 18 indexed citations
19.
Lavie, Muriel, et al.. (2004). Distribution and Sequence Analysis of a Family of Type III-Dependent Effectors Correlate with the Phylogeny of Ralstonia solanacearum Strains. Molecular Plant-Microbe Interactions. 17(8). 931–940. 27 indexed citations
20.
Lavie, Muriel, et al.. (2002). PopP1, a New Member of the YopJ/AvrRxv Family of Type III Effector Proteins, Acts as a Host-Specificity Factor and Modulates Aggressiveness of Ralstonia solanacearum. Molecular Plant-Microbe Interactions. 15(10). 1058–1068. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026